Navigation Links
Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
Date:6/20/2008

Automakers, Fleets Encouraged by New Biodiesel Standards

VANCOUVER, British Columbia, June 20 /PRNewswire/ -- The biodiesel industry is celebrating today following last night's final vote by the ASTM International D02 Main Committee to approve a trio of long-awaited ASTM specifications for biodiesel blends. After more than five years of extensive research and subsequent balloting by the ASTM fuel experts in the blended fuel balloting process, ASTM has finally voted to approve three key sets of biodiesel specifications that should significantly bolster automaker support and consumer demand for biodiesel:

- Changes to the existing B100 biodiesel blend stock specification (ASTM D6751)

- Finished specifications to include up to 5% biodiesel (B5) in the conventional petrodiesel specification (ASTM D975)

- A new specification for blends of between 6 percent biodiesel (B6) to 20 percent biodiesel (B20) for on and off road diesel.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080620/CLF034LOGO )

Automakers and engine manufacturers have been requesting a finished blend specification for B20 biodiesel blends for several years, with some citing the need for that spec as the single greatest hurdle preventing their full-scale acceptance of B20 use in their diesel vehicles.

Steve Howell, Chairman of the ASTM Biodiesel Task Force, said, "The new ASTM specifications for B6-B20 blends will aid engine manufacturers in their engine design and testing processes to optimize the performance of vehicles running on biodiesel. The new specifications will also help ensure that only the highest quality biodiesel blends are made available to consumers at the retail pump."

Automaker Chrysler LLC was instrumental in working with the ASTM task force toward B20 specification development and approval, having supported fleet use of B20 in its Dodge
'/>"/>

SOURCE National Biodiesel Board
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
2. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
3. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
4. FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
5. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
6. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
7. Medicare Approves in Home Sleep Apnea Testing
8. 3SBio Inc. Approves Share Repurchase Program
9. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
10. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
11. FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , QUEBEC CITY, Dec. 2 /PRNewswire-Firs...X: AEZ) (the "Company"), a global biopharmaceutica...y, today announced that the U.S. Food and Drug Adm...on for the Company,s PI3K/Akt pathway inhibitor co...f relapsed/refractory multiple myeloma. Keryx Biop...
(Date:12/2/2009)... , , HOBOKEN, N.J., Dec. 2 /PRNewswire/ ...40 percent to 45 percent of Americans diagnosed wi...tinopathy. Diabetic retinopathy, damage to the re...se of blindness in people with diabetes and is one...ct, up to 80 percent of all patients who,ve had di...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,.../www.reportlinker.com/p0164494/Chromium---Global-M...mium is primarily influenced by stainless steel, w...e markets is also important for growth of chromium...
(Date:12/1/2009)... , , PLYMOUTH, Mass., Dec. 1 /PRNewswire/...om ) announced today results from the company spon...amachandra Medical Center in Chennai, India using ...on-reconstructable Critical Limb Ischemia (CLI). S... international-associated institution based in Che...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...Q4 2007 sales increased 78.8% compared to Q4 2006 ...d to Q3 2007 -- Estimated sales for FY ... YORK, March 5 /Xinhua-PRNewswire-FirstCall/ -- Ch...d: CYXI), a leading provider in the,nutraceutical ...nd,distribution of organic nutritional food produc...
...LS, Mass., March 5 Joseph F. Finn, Jr.,CPA, the A...cs, confirmed,today that the sale of ActivBiotics,...sealed bid at 12:00 PM on March 14, 2008. There ha...bout different aspects of the,technology. "With 48...tion,to comprehensive due diligence, I believe we,...
...anagement Changes Announced, NEW YORK, March 5 B...nounced that the company,s Board of Directors,has ...hief financial,officer, effective March 31, 2008. ...ecting and managing the company,s fiscal operation...he organization and its,subsidiaries. Andrew Bonfi...
Other Biology Technology:China Yingxia International Announces Q4 and FY 2007 Estimates 2China Yingxia International Announces Q4 and FY 2007 Estimates 3Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 2Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 3
(Date:12/2/2009)... turns out that wearing a cap is good for you, at ...om the Johns Hopkins Engineering in Oncology Cente..." of thread-like fibers holds the cell,s nucleus, ...standing this cap,s influence on cell and nuclear ... the diagnosis and treatment of diseases such as c...
(Date:12/2/2009)... , REDWOOD CITY, Calif., Dec. 2 /PRNewswire/ -...entity and authentication solutions, today announc...its DigitalPersona biometric fingerprint technolog...rsona U.are.U® 4500HD offering allows point-o...ntify users so that specific transactions can be l...
(Date:12/2/2009)...York, NY, December 2, 2009 Commonly prescribed be... asthma in pregnant women as well as pre-term labo...sorders, psychiatric pathology, cognitive problems...cording to a new study published in the December 2... Gynecology . , Beta 2 adrenergic agonist drugs ...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Winner Medical Schedules 2008 2009 Third Quarter Earnings Release on Tuesday August 11 2009 53833 1Winner Medical Schedules 2008 2009 Third Quarter Earnings Release on Tuesday August 11 2009 53833 2Former Microsoft Healthcare Executive Joins iMedExchange 53828 1Former Microsoft Healthcare Executive Joins iMedExchange 53828 2Shamir Optical Industry Ltd to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 53823 1Shamir Optical Industry Ltd to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 53823 2
...er bees, wasps, and ants are often considered neut...ies, who although unable to mate, can lay unfertil...e species, such as bumble bees, this is the source...s, like the honeybee, workers "police" each other ...aying workers. , In 1964 the English biologist W...
...m from a West Indian tarantula has been shown to c... that sense high temperatures and the hot, spicy i...iscovered. , The findings demonstrate that some pl...trategy to deter predators -- triggering pain by a...he research provides new tools to understand how t...
...splanted neural stem cells hold promise for reduci...rs in Parkinson’s disease and for replacing cells ...ublished in the current issue of The Journal of Ne...nt essentially enables an animal model for Parkins...displaying the progressive loss of movement contro...
Other Biology News:Why do some queen bees eat their worker bee's eggs? 2Tarantula venom and chili peppers target same pain sensor 2Transplanted brain cells hold promise for Parkinson's disease 2Transplanted brain cells hold promise for Parkinson's disease 3
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Human VEGF R3 / Flt-4 Monoclonal Antibody, Phycoerythrin Conjugated, Clone 54733 from R&D Systems
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Mouse Anti-Human Cystatin F Monoclonal Antibodies, 292103 from R&D Systems
Biology Products: